Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1763-2025

LifeShield Drug Library Management (DLM), LifeShield Infusion Safety Software SUite v2.1 and v2.2 Recall

LifeShield Drug Library Management (DLM), LifeShield Infusion Safety Software SUite v2.1 and v2.2

FDA recall Class II

Ongoing

FDA lists this Class II recall for LifeShield Drug Library Management (DLM), LifeShield Infusion Safety Software SUite v2.1 and v2.2. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1763-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
May 2, 2025
FDA report date
May 21, 2025
Quantity in commerce
12 US, 3 OUS
Distribution
See key details
FDA cause
Software Design Change

What is being recalled?

LifeShield Drug Library Management (DLM), LifeShield Infusion Safety Software SUite v2.1 and v2.2

Affected model & UDI checker

Search the exact identifiers published for Z-1763-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedLifeShield Drug Library Management (DLM), LifeShield Infusion Safety Software SUite v2.1 and v2.2Check source notice00887709122802
FDA code information

LifeShield Infusion Safety Software Suite v2.1 and v2.2 UDI-DI 00887709122802

View the original FDA recall notice

Why was this product recalled?

Firm has identified Drug Library Management defects in the software: 1) DLM software does not allow user to create percentage dose rate or rate change values with certain limits, potentially resulting in over-delivery to patient. 2) An unauthorized user may modify and approve a drug library, potentially leading to incorrect program parameters being used for therapy.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Icu Medical, Inc. take?

Firm began notifying consignees on May 2, 2025 via hand delivery of letters titled "Urgent Medical Device Correction." Issue 1: User receives an error if they attempt to define a Percentage Dose Change Increase limit between 60% and 99%. Customers were instructed to ensure all users or potential users of the software are made aware of the notification and proposed mitigations: Use Percentage Dose Change Increase values between 20% and 59% or between 100% and 500%. Pharmacists will not be able to use values from 60% to 99%. Issue 2: It is possible for an unauthorized user to bypass the reauthentication steps required to approve a drug library or delete a medication ruleset. Customers were instructed to ensure all users or potential users are made aware of the notification and proposed mitigation: Communicate with all users the need to log off after finishing a session before leaving the workstation and following cybersecurity best practices. ICU Medical is developing a LifeShield software update to correct both issues.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology